BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32390177)

  • 1. Resuming work gradually in the context of COVID-19: Experience from a tertiary dermatology department in China.
    Tang K; Zhang H; Jin H
    Dermatol Ther; 2020 Jul; 33(4):e13554. PubMed ID: 32390177
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of COVID-19 outbreak on dermatology services: Dermatology in isolation.
    Damevska K; Neloska L; Simeonovski V; Petrov A; Dimitrovska I; Teovska-Mitrevska N; Najdova A; Pollozhani N
    Dermatol Ther; 2020 Jul; 33(4):e13552. PubMed ID: 32390176
    [No Abstract]   [Full Text] [Related]  

  • 3. The skin in the era of coronavirus pandemic.
    Ring J
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1384-1385. PubMed ID: 32678512
    [No Abstract]   [Full Text] [Related]  

  • 4. Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in COVID-19 era.
    Schwartz RA; Pradhan S; Galadari H; Lotti T; Sharma A; Goldust M
    Dermatol Ther; 2020 Jul; 33(4):e13806. PubMed ID: 32530538
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing aesthetic and conventional dermatology practice in the COVID-19 era.
    Arora G; Jafferany M; Arora S
    Dermatol Ther; 2020 Jul; 33(4):e13620. PubMed ID: 32431094
    [No Abstract]   [Full Text] [Related]  

  • 6. The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19.
    Freeman EE; McMahon DE; Fitzgerald ME; Fox LP; Rosenbach M; Takeshita J; French LE; Thiers BH; Hruza GJ
    J Am Acad Dermatol; 2020 Aug; 83(2):509-510. PubMed ID: 32305438
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.
    Sadoughifar R; Goldust M; Kroumpouzos G; Szepietowski JC; Lotti T; Sandhu S
    Dermatol Ther; 2020 Jul; 33(4):e13562. PubMed ID: 32396251
    [No Abstract]   [Full Text] [Related]  

  • 8. Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
    Shanshal M
    J Drugs Dermatol; 2020 Apr; 19(4):436. PubMed ID: 32401460
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial intelligence in diagnosis and management of COVID-19 in dermatology.
    Sadoughifar R; Goldust M; Abdshahzadeh H; Abrishamchi R; Rudnicka L; Jafferany M; Gupta M
    Dermatol Ther; 2020 Jul; 33(4):e13794. PubMed ID: 32511846
    [No Abstract]   [Full Text] [Related]  

  • 10. Teledermatology during COVID-19 pandemic: Ethical and legal considerations about the principles of treatment prescription and privacy.
    Elmas ÖF; Demirbaş A; Atasoy M; Türsen Ü; Lotti T
    Dermatol Ther; 2020 Jul; 33(4):e13781. PubMed ID: 32506548
    [No Abstract]   [Full Text] [Related]  

  • 11. A dermatologist's perspective of the COVID-19 outbreak.
    Murrell DF; Arora G; Rudnicka L; Kassir M; Lotti T; Goldust M
    Dermatol Ther; 2020 Jul; 33(4):e13538. PubMed ID: 32385938
    [No Abstract]   [Full Text] [Related]  

  • 12. Virtual dermatopathology: A potential educational tool during COVID-19 pandemic.
    Khullar G; Chandra M
    Dermatol Ther; 2020 Jul; 33(4):e13755. PubMed ID: 32495961
    [No Abstract]   [Full Text] [Related]  

  • 13. Where do we stand as dermatologists in combat with COVID-19.
    Goldust M; Shivakumar S; Kroumpouzos G; Murrell DF; Mueller SM; Navarini AA
    Dermatol Ther; 2020 Jul; 33(4):e13638. PubMed ID: 32441435
    [No Abstract]   [Full Text] [Related]  

  • 14. How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.
    Radi G; Simonetti O; Diotallevi F; Campanati A; Brisigotti V; Molinelli E; Offidani A
    Dermatol Ther; 2020 Jul; 33(4):e13740. PubMed ID: 32478970
    [No Abstract]   [Full Text] [Related]  

  • 15. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-west Poland.
    Białynicki-Birula R; Siemasz I; Otlewska A; Matusiak Ł; Szepietowski JC
    Dermatol Ther; 2020 Jul; 33(4):e13738. PubMed ID: 32478949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To resume outpatient dermatologic surgery safely during stabilized period of coronavirus disease-2019: Experiences from Wuhan, China.
    Yang L; Song Z; Qian Y; Tao J
    Dermatol Ther; 2020 Jul; 33(4):e13522. PubMed ID: 32378276
    [No Abstract]   [Full Text] [Related]  

  • 18. Thinking outside the box in COVID-19 era-Application of modified aerosol box in dermatology.
    Babu B; Shivakumar S; Asokan K
    Dermatol Ther; 2020 Jul; 33(4):e13769. PubMed ID: 32500633
    [No Abstract]   [Full Text] [Related]  

  • 19. International collaboration and rapid harmonization across dermatologic COVID-19 registries.
    Freeman EE; McMahon DE; Hruza GJ; Irvine AD; Spuls PI; Smith CH; Mahil SK; Castelo-Soccio L; Cordoro KM; Lara-Corrales I; Naik HB; Alhusayen R; Ingram JR; Feldman SR; Balogh EA; Kappelman MD; Wall D; Meah N; Sinclair R; Beylot-Barry M; Fitzgerald M; French LE; Lim HW; Griffiths CEM; Flohr C
    J Am Acad Dermatol; 2020 Sep; 83(3):e261-e266. PubMed ID: 32562840
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the dermatology communities' public health response to COVID-19.
    Gorrepati PL; Smith GP
    Dermatol Ther; 2020 Jul; 33(4):e13775. PubMed ID: 32506777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.